SCHEMBL23725656

SCHEMBL23725656

Cc1c(Br)cccc1-n1ccc(CN(CCO)C(=O)O)cc1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTGES O14684 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
JAK2 O60674 3/20 0.33
BTK Q06187 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25664077 0.86 SSTR4 (0.43) PDCD1CD274L3MBTL1JAK2BTK
SCHEMBL30432880 0.86 SSTR4 (0.43) PDCD1CD274L3MBTL1JAK2BTK
SCHEMBL23726028 0.80 JAK2 (0.39) KMT2AJAK2BTKHPGDLMNA
SCHEMBL23726142 0.76 CD274 (0.46) PDCD1CD274JAK2BTK
SCHEMBL23725320 0.75 JAK2 (0.39) KMT2AJAK2BTKHPGDLMNA
SCHEMBL23725659 0.73 L3MBTL1 (0.36) PDCD1CD274L3MBTL1SMN1; SMN2JAK2
SCHEMBL23725295 0.73 ALDH1A1 (0.35) PDCD1CD274NPC1RAB9AALDH1A1
SCHEMBL268819 0.70 L3MBTL1 (0.50) NPC1RAB9AALDH1A1KMT2AMEN1
SCHEMBL28903500 0.69 JAK2 (0.41) KMT2AJAK2BTKHPGDLMNA
SCHEMBL23724945 0.67 JAK2 (0.40) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA CORP (US) 2023-05-11 US disclosed
EP-4100381-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2022-12-14 EP disclosed
WO-2021158481-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2021-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143612-A1 SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS AND METHODS USING SAME HAVCR2, HMBS, VHL PDCD1 62/4885CD274 75/4885NPC1 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.